Jianxin N. Du

54 Gongqingtuan Road
Zibo, 255000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Nanoparticle-Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple-Negative Breast Cancer by Modulating RAB7A Ubiquitination-Associated Stability and Autophagy.

Nanoparticle-Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple-Negative Breast Cancer by Modulating RAB7A Ubiquitination-Associated Stability and Autophagy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 03, 2025

Enhancing antitumor immunity in triple-negative breast cancer through reversal of T-cell exhaustion using a CD8-targeted and membrane-camouflaged nanocarrier delivering small interfering RNA against sorting Nexin 9.

Enhancing antitumor immunity in triple-negative breast cancer through reversal of T-cell exhaustion using a CD8-targeted and membrane-camouflaged nanocarrier delivering small interfering RNA against sorting Nexin 9.

Journal: Journal of nanobiotechnology

Published: November 19, 2025

Author Correction: Interferon signaling and ferroptosis in tumor immunology and therapy.

Author Correction: Interferon signaling and ferroptosis in tumor immunology and therapy.

Journal: NPJ precision oncology

Published: January 11, 2025

TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma.

TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma.

Journal: eLife

Published: December 27, 2024

NGR-Modified CAF-Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma.

NGR-Modified CAF-Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 07, 2024

Corrigendum to: C-reactive protein is associated with the development of tongue squamous cell carcinoma.

Corrigendum to: C-reactive protein is associated with the development of tongue squamous cell carcinoma.

Journal: Acta biochimica et biophysica Sinica

Published: December 21, 2023

Correction to: Cl-amidine attenuates lipopolysaccharide-induced inflammation in human gingival fibroblasts via the JNK/MAPK, NF-κB, and Nrf2 signalling pathways.

Correction to: Cl-amidine attenuates lipopolysaccharide-induced inflammation in human gingival fibroblasts via the JNK/MAPK, NF-κB, and Nrf2 signalling pathways.

Journal: Human cell

Published: February 15, 2023

TIPE2 sensitizes breast cancer cells to paclitaxel by suppressing drug-induced autophagy and cancer stem cell properties.

TIPE2 sensitizes breast cancer cells to paclitaxel by suppressing drug-induced autophagy and cancer stem cell properties.

Journal: Human cell

Published: November 22, 2022

Cl-amidine attenuates lipopolysaccharide-induced inflammation in human gingival fibroblasts via the JNK/MAPK, NF-κB, and Nrf2 signalling pathways.

Cl-amidine attenuates lipopolysaccharide-induced inflammation in human gingival fibroblasts via the JNK/MAPK, NF-κB, and Nrf2 signalling pathways.

Journal: Human cell

Published: March 24, 2022

Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.

Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.

Journal: Clinical radiology

Published: September 30, 2021

Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.

Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.

Journal: The Journal of international medical research

Published: August 11, 2020

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2.

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2.

Journal: OncoTargets and therapy

Published: June 07, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026